Determination of the pyridinium metabolite derived from haloperidol in brain tissue, plasma and urine by high-performance liquid chromatography with fluorescence detection
- 4 September 1992
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 579 (2) , 277-283
- https://doi.org/10.1016/0378-4347(92)80392-4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Identification of potentially neurotoxic pyridinium metabolite in the urine of schizophrenic patients treated with haloperidolBiochemical and Biophysical Research Communications, 1991
- Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metaboliteChemical Research in Toxicology, 1991
- Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in ratsBiochemical and Biophysical Research Communications, 1990
- A fluorometric determination of N-methyl-4-phenylpyridinium ion, using high-performance liquid chromatographyAnalytical Biochemistry, 1987
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Pargyline Prevents MPTP-Induced Parkinsonism in PrimatesScience, 1984
- Haloperidol kinetics after oral and intravenous dosesClinical Pharmacology & Therapeutics, 1983
- Isolation and Identification of a Metabolite of HaloperidolJournal of Analytical Toxicology, 1981